Distinct Immunogenicity and Efficacy of Poxvirus-based Vaccine Candidates against Ebola Virus expressing GP and VP40 Proteins.
about
Distinct Immunogenicity and Efficacy of Poxvirus-based Vaccine Candidates against Ebola Virus expressing GP and VP40 Proteins.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
Distinct Immunogenicity and Ef ...... pressing GP and VP40 Proteins.
@en
Distinct Immunogenicity and Ef ...... pressing GP and VP40 Proteins.
@nl
type
label
Distinct Immunogenicity and Ef ...... pressing GP and VP40 Proteins.
@en
Distinct Immunogenicity and Ef ...... pressing GP and VP40 Proteins.
@nl
prefLabel
Distinct Immunogenicity and Ef ...... pressing GP and VP40 Proteins.
@en
Distinct Immunogenicity and Ef ...... pressing GP and VP40 Proteins.
@nl
P2093
P2860
P356
P1433
P1476
Distinct Immunogenicity and Ef ...... pressing GP and VP40 Proteins.
@en
P2093
Adrián Lázaro-Frías
César Muñoz-Fontela
Juan García-Arriaza
Karl Ljungberg
Lucas Sánchez-Sampedro
Mariano Esteban
Mart Ustav
Peter Liljeström
Sergio Gómez-Medina
P2860
P356
10.1128/JVI.00363-18
P407
P577
2018-03-07T00:00:00Z